Clinical trials
Phase 3 trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
924 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 11 |
| 2002 | 9 |
| 2003 | 15 |
| 2004 | 15 |
| 2005 | 35 |
| 2006 | 41 |
| 2007 | 46 |
| 2008 | 41 |
| 2009 | 50 |
| 2010 | 38 |
| 2011 | 31 |
| 2012 | 39 |
| 2013 | 36 |
| 2014 | 34 |
| 2015 | 35 |
| 2016 | 34 |
| 2017 | 37 |
| 2018 | 40 |
| 2019 | 36 |
| 2020 | 44 |
| 2021 | 40 |
| 2022 | 31 |
| 2023 | 49 |
| 2024 | 54 |
| 2025 | 53 |
| 2026 | 18 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 540 |
| Active, not recruiting | 132 |
| Recruiting | 107 |
| Terminated | 105 |
| Unknown status | 29 |
| Enrolling by invitation | 4 |
| Withdrawn | 4 |
| Suspended | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 84 |
| Novartis Pharmaceuticals | 69 |
| AstraZeneca | 65 |
| GlaxoSmithKline | 46 |
| Merck Sharp & Dohme LLC | 39 |
| Pfizer | 37 |
| Bristol-Myers Squibb | 36 |
| Boehringer Ingelheim | 34 |
| Chinese University of Hong Kong | 34 |
| Amgen | 32 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 84 |
| Breast Neoplasms | 64 |
| Diabetes Mellitus, Type 2 | 51 |
| Carcinoma, Hepatocellular | 34 |
| Neoplasms | 32 |
| Lung Neoplasms | 23 |
| Neoplasm Metastasis | 22 |
| Colorectal Neoplasms | 20 |
| Diabetes Mellitus | 20 |
| Liver Neoplasms | 17 |
Trials
Showing 1 to 25 of 924. Each trial links to its page on Pharma Observatory.
824 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.